Main Content
TearClear is developing a chemical filter technology designed to capture and reduce the concentration of preservatives commonly used in multi-dose ophthalmic solutions.
What People are Saying
BAK has been shown to be a significant cause of a host of adverse events with prolonged use… TearClear’s technology offers a compelling and differentiated approach to eliminating the preservative before delivery while allowing it to preserve sterility within the bottle.
Richard Lindstrom, MD
Ophthalmology has been looking to address this unmet need for a long time. TearClear is developing a simple and effective technology that will truly benefit the patient.
Bill Link, PhD